Abstract
MDS is a heterogeneous clonal stem cell disorder with trilineage dysplasia resulting in ineffective, monoclonal hematopoiesis ([Resegotti et al., 1993]). Extensive studies over the decade have led to better understanding of cell proliferation, differentiation, cytokine production and apoptosis in MDS ([Greenburg et al., 1987]; [Shetty et al., 1996]; [Clark et al., 1990]; [Yoshida et al., 1993]; [Raza et al., 1995]). However there has been limited information in the literature regarding long term bone marrow cultures and ultrastructural studies performed on MDS. In the past, it has been difficult to grow MDS bone marrow (BM) cells as the progenitor cells have a great propensity to undergo programmed cell death ([Ohmori et al., 1991]; [Aizawa et al., 1999]; [Raza et al., 1996]). On the other hand the role of electron microscopy has not been clearly established in MDS either, other than few individual cases on BM aspirate because of the failure to overcome the technical impediment of maintaining the ultrastructural details in decalcified tissues ([Guccion et al., 1992]; [Gerrad et al., 1992]; [Cohen et al., 1997]; [Payne et al., 1987]). As a result very little is known about the association between the hematopoietic cells and their microenvironment especially in a disease like MDS where both the parenchymal and stromal cells may be involved in the disease process ([Coutinho et al., 1990]; [Sawada et al., 1998])). The present chapter focuses on novel techniques where primarily the MDS core bone marrow biopsy was used to maintain long term bone marrow cultures followed by ultrastructural studies, hence preserving the BM architecture and the geographical distribution of the hematopoietic and stromal cells as they existin vivo.A number of novel and interesting observations were made which are summarized here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aizawa, S., Nakano, M., Iwase, O., Yaguchi, M., Hiramoto, M., Hoshi, H., Nabeshima, R., Shima, D., Banda, H., & Toyama, K, (1999) Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro.Leukemia Research23, 239–246.
Alvi, S., Shaher, A., Henderson, B., Dar, S., Zorat, F., Broderick, E., Lisak, L., Du Randt, M., Reddy, P., Mundle, S., Galili, N., Borok, R.Z., & Raza, A, (2000) Improved growth of stromal cells in long term bone marrow cultures (LTBMC) of myelodysplastic syndrome (MDS) patients treated with thalidomide.Blood96, 359a. Abstract #1547.
Bennett, J.M., Catovsky, D., Flandrin, D.M.T., Galton, G.D.A.G., Gralnick, H.R., & Sultan, C., (1982) Proposal for the classification of the myelodysplastic syndromes.British Journal of Haematology51,189–199.
Blazsek, I., Liu, X.H., Anjo, A., Quittet, P., Comisso, M., Kim-Triana, B & Misset, J.L, (1995) The hematon, a morphogenetic functional complex in mammalian bone marrow, involves erythroblastic islands and granulocytic cobblestones.Experimental Hematology23, 309–319.
Bogdanovic, A.D., Jankovic, G.M., Colovic, M.D., Trpinac, D.P., & Bumbasirevic, V.Z, (1996) Apoptosis in bone marrow of myelodysplastic syndrome patients.Blood87, 3064.
Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F., & Fontenay-Roupie, M, (1997) Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.Leukemia 11839–845.
Chang, J., & Dexter, T.M. (1991) Long—term cultures: in vitro purging of leukemic cells.Baillieres Clinical Haematology3:775–788.
Clark, D.M., & Lampert, I.A., (1990) Apoptosis is a common histopathological finding in myelodysplasia: the correlate of ineffective hematopoiesis.Leukemia Research2, 415–418.
Cohen, A., Alexandrova, S., Kessler, H., Mittelman, M., Cycowitz, Z.&Djaldetti, M, (1997) Ultrastructural observation on bone marrow cells of 26 patients with myelodysplastic syndromes.Leukemia &Lymphoma27, 165–172.
Coutinho, L.H., Geary, C.G., Chang, J., Harrison, C., & Testa, N.G, (1990) Functional studies of bone marrow haemopoietic and stromal cells in the myelodysplastic syndromes (MDS).British Journal of Haematology75, 16–25.
Davey, F. R., Erber, W. N., & Gatter, K.C., (1988) Abnormal neutrophils in acute leukemia and myelodysplastic syndrome.Human Pathology19, 454–459.
Dexter, T.M, (1979) Haemopoiesis in long term bone marrow cultures.Acta Haematologia62, 299–305.
Diana, C., Dominici, M., Lanza, F., Punturieri, M., Pauli, S., Tieghi, A., Dabusti, M., Scapoli, G., & Castoldi, G, (2000) Impairment of stromal cells compartment in hypoplastic myelodysplastic syndromes.Blood96, 357a. Abstract # 1541.
Duhrsen, U., & Hossfeld, D.K, (1996) Stromal abnormalities in neoplastic bone marrow diseases.Annals ofHematology 7353–70.
Gerrad, J.M., & McNicol, A, (1992) Platelet storage pool deficiency, leukemia, and myelodysplastic syndromesLeukemia & Lymphoma8, 277–281.
Gidali, J., Feher, I & Hollan, S.R, (1996) Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.Stem Cells14, 577–583.
Greenburg, P.L, (1992) In vitro marrow culture studies in the myelodysplastic syndromes.Seminars in Oncology1, 34–46.
Greenburg, P.L. (1987) Biologic nature of the myelodysplastic syndromes.Acta Haematologica78, 94–99.
Guccion, J.G., Schechter, G.P., & Zeller, J, (1992) Cytomembranous inclusions in myelodysplastic syndromes.Ultrastructural Pathology16, 521–527.
Kouides, P.A., & Bennett, J.M, (1992) Morphology and classification of myelodysplastic syndromes [review].Hematology Oncology Clinics of North America6, 485–499.
Lanotte, M., Allen, T.D., & Dexter, M.T., (1981) Histochemical and ultrastructural characteristics of a cell line from human bone marrow stroma.Journal of Cell Science50, 281–297.
Lai, J.L., & Fenaux, P, (1997) Cytogenetics of myelodysplastic syndromes.Pathological Biology45, 550–555.
Lepelley, P., Campergue, L., Grardel, N., Preudhomme, C., Cosson, A., Fenaux, P, (1996) Is apoptosis a massive process in myelodysplastic syndromes?British Journal of Haematology95, 368–371.
Ohmori, M., Ohmori, S., Ueda, Y., Yoshida, Y., & Okuma, M, (1991) Ineffective hematopoiesis in myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.International Journal of Cell Cloning9, 521–530.
Payne, C.M., Greenberg, B., Cromey, D., & Woo, L, (1987) Morphological evidence of an altered bone marrow microenvironment in patients with acute nonlymphoblastic leukemia and myelodysplastic disorders.Experimental. Hematology15, 143–153.
Parcharidou, A., Raza, A., Economopoulos, T., Papageorgiou, E., Anagnostou, D., Papadaki, T., & Raptis, S, (1999) Extensive apoptosis of bone marrow cells as evaluated by in situ end-labeling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.European Journal of Haematology62, 19–26.
Pedersen-Bjergaard, J., Philip, P., Larsen, S.O., Anderson, M., Daugaard, G., Ersboll, J., Hansen, S.W., Hou-Jensen, K., Nielsen, D., Sigsgaard, T.C., Specht, L., & Osterlind, K, (1993) Therapy related myelodysplastic syndromes and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.Leukemia7, 1975–1986.
Polli, N., O’Brien M., Tavares, de., Castro, J., Matutes, E., San Miguel, J.F., & Catovsky, D, (1995) Characterization of blast cells in chronic granulocytic leukemia in transformation, acute myelofibrosis and undifferentiated leukemia. 1. Ultrastructural Morphology and Cytochemistry.British. Journal Haematology59, 277–296.
Raza, A., Mundle, S., Iftikhar, A., Gregory, S., Marcus, B., Khan, Z., Alvi, S., Shetty, V., Dameron, S., Wright, V., Adler, S., Loew, J., Scott, S., Ali, S.N., & Preisler, H.D., (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis.American Journal of Hematology48, 143–154.
Raza, A., Gezer, S., Mundle, S., Gao, X.Z., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, B., Khan, Z., Chaney, C., Showel, J., Gregory, S., & Preisler, H.D, (1996) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood86, 268–276.
Raza, A., Alvi, S., Borok, R.Z., Span, L., Parcharidou, A., Alston, D., Rifkin, S., Robin, E., Shah, R., & Gregory, S.A, (1997).Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: The cause-effect relationship.Leukemia & Lymphoma27(1–2), 111–118.
Resegotti, L., (1993) The nature and natural history of myelodysplasia.Haematologia25, 191–204.
Sawada, K, (1998) Growth characteristics of myelodysplastic CD34+ cells.Leukemia & Lymphoma„29, 49–60.
Seed, T.M., Husseini, S.G., & Knospe, W.H, (1986) Hematopoiesis on cellulose ester membranes: VII. Ultrastructure of stroma of marrow enriched membranes with trilineal hematopoiesis.Experimental Hematology14, 108–118.
Shetty, V., Mundle, S, Alvi, S., Showel, M., Broady-Robinson, L., Dar, S., Borok, R., Showel, J., Greagory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominguez, C.&Raza, A, (1996) Measurement of apoptosis, proliferation and three cytokine in 46 patients with myelodysplastic syndromes.Leukemia Research20, 891–900.
Vallespi, T., Imbert, M., Mecucci, C., Preudhomme, C., & Fenaux, P, (1998) Diagnosis, classification, and cytogenetics of myelodysplastic syndromes.Haematologica83, 258–275.
Verhoef, G.E.G, Pittaluga, S., De Wolf- Peters, C., & Boogaerts, M.A., (1995) FAB classification of myelodysplastic syndromes: merits and controversies.Annals of Hematology71, 3–11.
Weimar, I. S., Bourhis, J.H., De Gast, G.C., & Gerritsen, W.R, (1994) Clonality in myelodysplastic syndromes.Leukemia & Lymphoma13, 215–221.
Weiss, L., (1976) The hematopoietic microenvironment of the bone marrow: An ultrastructural study of the stroma in rat.Anatomica. Records186, 161–184.
Yoshida, Y., (1993) Apoptosis may be the mechanism responsible for the premature intramedullary cell death in myelodysplastic syndromes.Leukemia7, 144–146.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Alvi, S., Lisak, L.A., Shetty, V.T. (2001). Novel in Vitro Culture and Ultrastructural Techniques to Study the Biology of Myelodysplastic Syndromes (MDS). In: Raza, A., Mundle, S.D. (eds) Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia. Cancer Treatment and Research, vol 108. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1463-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1463-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5566-3
Online ISBN: 978-1-4615-1463-3
eBook Packages: Springer Book Archive